Examples of interdisciplinary workshop presentations given 2015 - 2016 include the following:
Marty Solomon, M.D., Pulmonary, Allergy & Critical Care Medicine
"Methods to interrogate mechanisms of altered ciliary dynamics and mucus transport"
Michael Stalvey, M.D., Pediatrics - Endocrinology
"Pathogenesis and mortality of CFRD: yesterday, today and tomorrow"
Namasivayam Ambalavanan, M.D., Pediatrics - Neonatology
"Normal and abnormal lung development and its relevance to adult lung diseases"
Tamas Jilling, M.D., Pediatrics - Neonatology
"Why would you want to study the rold of platelet-activating factor (PAF) in CF pathogenesis?"
Vedrana Bali, M.D., Ph.D., Cellular, Developmental & Integrative Biology
"Synonymous but not the same. A synonymous codon change alters ΔF508 CFTR corrector sensitivity"
Kathryn Oliver, Ph.D. Candidate (Mentor: Eric J. Sorscher)
"Ribosomal P Stalk pertubation rescues F508del CFTR maturational arrest"
Zhengrong (Wendy) Yang, Ph.D., Center for Biophysical Sciences/Engineering
"Interactions and cooperativity between P-glycoprotein structual domains determined by thermal unfolding"
Rui-Ming Liu, M.D., Ph.D., Pulmonary, Allergy & Critical Care Medicine
"Therapeutic potential of a small molecular PAI-1 inhiibitor for chronic asthma"
James Collawn, Ph.D., Cellular, Developmental, & Integrative Biology
"Regulation of hypoxia-inducible factor 1alpha expression by miR-429 in human endothelial cells"
Veena Antony, M.D., Pulmonary, Allergy & Critical Care Medicine
"Environmental exposure to Cadmium and the development of COPD"
Brad Woodworth, M.D., Surgery - Otolaryngology
"LPS-mediated acquired CFTR dysfunction in chronic sinusitis"
Steve Rowe, M.D., Director, CF Research Center
"State of the Center"
J. Michael Wells, M.D., Pulmonary, Allergy & Critical Care Medicine
"Translational and Clinical Approaches to Pulmonary Hypertension in Cystic Fibrosis"
Note: Other regularly scheduled workshops (not shown above) include 1) rehearsal sessions for UAB talks in preparation for NACFC, 2) CF journal club, 3) review of the European CF meetings (provided by Drs. Bebok and Rowe), and 4) discussions regarding grant opportunities from NIH (RFAs, PAs. etc.).